KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Other Non-Current Liabilities (2019 - 2025)

LifeMD (LFMD) has disclosed Other Non-Current Liabilities for 7 consecutive years, with $100000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $100000.0, compared with a TTM value of $100000.0 through Sep 2025, changed 0.0%, and an annual FY2024 reading of $100000.0, down 23.81% over the prior year.
  • Other Non-Current Liabilities was $100000.0 for Q3 2025 at LifeMD, roughly flat from $100000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $5.7 million in Q1 2022 and bottomed at $100000.0 in Q4 2021.
  • Average Other Non-Current Liabilities over 5 years is $880453.1, with a median of $115625.0 recorded in 2021.
  • The sharpest move saw Other Non-Current Liabilities soared 343.75% in 2022, then tumbled 93.31% in 2023.
  • Year by year, Other Non-Current Liabilities stood at $100000.0 in 2021, then skyrocketed by 343.75% to $443750.0 in 2022, then plummeted by 70.42% to $131250.0 in 2023, then fell by 23.81% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for LFMD at $100000.0 in Q3 2025, $100000.0 in Q2 2025, and $100000.0 in Q1 2025.